DE3584866D1 - Hybridpartikel-immunogene. - Google Patents
Hybridpartikel-immunogene.Info
- Publication number
- DE3584866D1 DE3584866D1 DE8585111431T DE3584866T DE3584866D1 DE 3584866 D1 DE3584866 D1 DE 3584866D1 DE 8585111431 T DE8585111431 T DE 8585111431T DE 3584866 T DE3584866 T DE 3584866T DE 3584866 D1 DE3584866 D1 DE 3584866D1
- Authority
- DE
- Germany
- Prior art keywords
- atcc
- september
- deposited
- expression
- dna sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Revoked
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65032384A | 1984-09-12 | 1984-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE3584866D1 true DE3584866D1 (de) | 1992-01-23 |
Family
ID=24608410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8585111431T Revoked DE3584866D1 (de) | 1984-09-12 | 1985-09-10 | Hybridpartikel-immunogene. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0175261B1 (de) |
JP (3) | JPH07108920B2 (de) |
AT (1) | ATE70308T1 (de) |
CA (1) | CA1263618A (de) |
DE (1) | DE3584866D1 (de) |
HK (1) | HK140195A (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4707357A (en) * | 1984-06-26 | 1987-11-17 | The United States Of America As Represented By The Secretary Of The Army | Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor |
ZA855232B (en) * | 1984-07-23 | 1986-02-26 | Univ New York | Protective peptide antigen corresponding to plasmodium falciparum circumsporozoite protein |
US4826957A (en) * | 1985-07-12 | 1989-05-02 | New York University | Immunogenic recombinant yeast expression product and method for purifying it |
JP2661044B2 (ja) * | 1986-06-17 | 1997-10-08 | カイロン コーポレイション | 肝炎δの診断薬およびワクチン |
GB2195340A (en) * | 1986-08-22 | 1988-04-07 | Malcolm Alistair Mccrae | Anti-viral vaccine |
US5041385A (en) * | 1986-11-01 | 1991-08-20 | Oxford Gene Systems Limited | Vector expressing fusion proteins and particles |
WO1988005817A1 (en) * | 1987-01-30 | 1988-08-11 | Smith Kline - Rit S.A. | Expression of the p. falciparum circumsporozoite protein by yeast |
AP56A (en) * | 1987-01-30 | 1989-09-26 | Smithkline Biologicals S A | Hepatitis B virus surface antigens and hybrid antigehs containing them. |
NZ219516A (en) * | 1987-02-10 | 1991-02-26 | Wellcome Found | Fusion proteins of hbcag (hepatitis b virus core antigen) |
NZ219515A (en) | 1987-02-10 | 1989-09-27 | Wellcome Found | Fusion proteins comprising influenza virus ha and a nonnatural antigenic epitope |
IL86833A0 (en) * | 1987-06-22 | 1988-11-30 | Medico Labs | Peptide containing immunogenic particles |
FR2635532B1 (fr) * | 1988-07-29 | 1992-05-22 | Pasteur Institut | Particules hbsag recombinantes hybrides : caracteristiques morphologiques de l'antigene hbsag contenant 1 sequence immunogene induisant des anticorps neutralisants diriges contre hiv ou susceptible d'etre reconnue par de tels anticorps; sequences nucleotidiques codant pour de telles particules; vaccins les contenant |
IL91462A0 (en) * | 1988-08-30 | 1990-04-29 | Applied Research Systems | Recombinant fusion proteins and dna encoding for such a protein |
JPH02115129A (ja) * | 1988-10-21 | 1990-04-27 | Kokuritsu Yobou Eisei Kenkyusho | 抗ウィルス剤 |
US5648241A (en) * | 1989-09-15 | 1997-07-15 | The General Hospital Corporation | Conjugate vaccine against group B streptococcus |
ATE163047T1 (de) * | 1990-08-15 | 1998-02-15 | Therion Biolog Corp | Selbstständig zusammenfügende replikationsdefekte hybride viruspartikel |
IT1241003B (it) * | 1990-11-05 | 1993-12-27 | Sorin Biomedica Spa | Procedimento per la purificazione di un polipeptide ricombinante hdag equivalente, polipeptide hdag equivalente e saggi immunologici che lo utilizzano |
EP0491077A1 (de) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | Zusammensetzung verwendbar als therapeutisches Mittel gegen chronische virale Leberkrankheiten |
US6040169A (en) | 1991-01-31 | 2000-03-21 | Medical Research Council | Herpes simplex virus-1 deletion variants and vaccines thereof |
GB9102126D0 (en) * | 1991-01-31 | 1991-03-13 | Smithkline Beecham Biolog | Novel vaccine |
WO1993010152A1 (en) * | 1991-11-16 | 1993-05-27 | Smithkline Beecham Biologicals S.A. | HYBRID PROTEIN BETWEEN CS FROM PLASMODIUM AND HBsAG |
GB9200117D0 (en) * | 1992-01-06 | 1992-02-26 | Connaught Lab | Production of recombinant chimeric proteins for vaccine use |
GB9202933D0 (en) * | 1992-02-12 | 1992-03-25 | Smithkline Beecham Biolog | Vaccines |
US6169171B1 (en) | 1992-02-27 | 2001-01-02 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBSAG |
US5928902A (en) * | 1992-02-27 | 1999-07-27 | Smithkline Beecham Biologicals (S.A.) | Hybrid protein between CS from plasmodium and HBsAg |
MA22842A1 (fr) * | 1992-03-27 | 1993-10-01 | Smithkline Beecham Biolog | Procede de preparation de compositions de vaccin. |
US6620414B2 (en) | 1992-03-27 | 2003-09-16 | Smithkline Beecham Biologicals (S.A.) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A |
ES2160601T3 (es) * | 1992-09-24 | 2001-11-16 | Brigham & Womens Hospital | Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina. |
ZA937034B (en) * | 1992-09-24 | 1995-06-23 | Brigham & Womens Hospital | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines |
WO1994016084A1 (en) * | 1993-01-16 | 1994-07-21 | British Bio-Technology Limited | Hybrid particle-forming protein comprising a particle-inducing segment and a plurality of antigens |
US6284884B1 (en) | 1995-06-07 | 2001-09-04 | North American Vaccine, Inc. | Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof |
PT1035133E (pt) | 1999-02-17 | 2005-05-31 | Pfizer Prod Inc | Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune |
JP2013500329A (ja) * | 2009-07-29 | 2013-01-07 | ヘルムート アダム レフム ベルン | ポリマー粒子およびその使用 |
KR101328752B1 (ko) * | 2012-03-19 | 2013-11-13 | 최석명 | 과채류용 멀칭비닐을 이용한 덮개 및 이의 제조방법 |
EP3011061B1 (de) * | 2013-06-21 | 2021-12-29 | The Johns Hopkins University | Virionenanzeigearray zum profilieren von funktionen und wechselwirkungen menschlicher membranproteine |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE52036B1 (en) * | 1979-05-24 | 1987-05-27 | Univ California | Non-passageable viruses |
GR76274B (de) * | 1981-08-04 | 1984-08-04 | Univ California | |
DE3378218D1 (en) * | 1982-04-15 | 1988-11-17 | Merck & Co Inc | Dna cloning vector tg1, derivatives, products and processes |
GB8421282D0 (en) * | 1984-08-22 | 1984-09-26 | Connaught Lab | Multispecific antigenic proteins |
-
1985
- 1985-09-10 DE DE8585111431T patent/DE3584866D1/de not_active Revoked
- 1985-09-10 EP EP85111431A patent/EP0175261B1/de not_active Expired - Lifetime
- 1985-09-10 AT AT85111431T patent/ATE70308T1/de not_active IP Right Cessation
- 1985-09-12 JP JP60200690A patent/JPH07108920B2/ja not_active Expired - Lifetime
- 1985-09-12 CA CA000490607A patent/CA1263618A/en not_active Expired
-
1994
- 1994-02-04 JP JP6012833A patent/JP2531498B2/ja not_active Expired - Lifetime
- 1994-02-04 JP JP6012834A patent/JP2659084B2/ja not_active Expired - Lifetime
-
1995
- 1995-08-31 HK HK140195A patent/HK140195A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2659084B2 (ja) | 1997-09-30 |
ATE70308T1 (de) | 1991-12-15 |
HK140195A (en) | 1995-09-08 |
EP0175261A2 (de) | 1986-03-26 |
EP0175261A3 (en) | 1988-01-07 |
EP0175261B1 (de) | 1991-12-11 |
JPS61129135A (ja) | 1986-06-17 |
JPH0739379A (ja) | 1995-02-10 |
JPH0746997A (ja) | 1995-02-21 |
CA1263618A (en) | 1989-12-05 |
JP2531498B2 (ja) | 1996-09-04 |
JPH07108920B2 (ja) | 1995-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3584866D1 (de) | Hybridpartikel-immunogene. | |
CA2020668A1 (en) | Fused or hybrid protein comprising viral antigen and lymphokine | |
DE3586189T2 (de) | Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute. | |
EP0278940A3 (de) | Hepatitis-B-Virus-Oberflächenantigene und sie enthaltende hybride Antigene | |
IE792494L (en) | Recombinant dna and their method of production | |
ES8305419A1 (es) | Un peptido | |
EP0370458A3 (de) | Von synthetischer DNS abgeleitete rekombinante HIV-1-Antigene | |
WO2000039302A3 (en) | Improved expression of hiv polypeptides and production of virus-like particles | |
ES8703520A1 (es) | Procedimiento de preparar particulas que contienen secuencias de aminoacidos y que tienen propiedades inmunogenas | |
PT83761A (en) | Method for producing mammalian interleukin-4 | |
PT96097A (pt) | Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados | |
EP0232798A3 (de) | Pseudorabies-Virus-Mutanten, diese enthaltende Vakzine, Verfahren zu deren Herstellung sowie Methoden für deren Anwendung | |
CA2089753A1 (en) | Interleukin-2-leukotoxin gene fusions and uses therefor | |
EP0174444A3 (en) | Hepatitis surface antigen particle vaccine | |
GR3007031T3 (de) | ||
DE3888290D1 (de) | Mutanten des infektiösen bovinen Rhinotracheitisvirus, Vakzine die sie enthalten, Verfahren zu ihrer Herstellung und ihrer Verwendung. | |
AU1321988A (en) | The cloning of malaria-specific dna sequences: isolation of the gene for the 140 kd protein | |
Lasky et al. | Production of an HSV subunit vaccine by genetically engineered mammalian cell lines. | |
EP1433851A3 (de) | Verbesserte exprimierung von HIV Polypeptiden und Herstellung von virusähnliche Partikeln | |
MY102686A (en) | Recombinant dna molecules and their method of production. | |
TH6216EX (th) | แอนติเจนที่ผิวของเฮพาไตติสมีไวรัสและแอนติเจนถูกผสม ซึ่งมีแอนติเจนที่ผิวของเฮปาไตติสมีไวรัส | |
TH6216A (th) | แอนติเจนที่ผิวของเฮพาไตติสมีไวรัสและแอนติเจนถูกผสม ซึ่งมีแอนติเจนที่ผิวของเฮปาไตติสมีไวรัส |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8331 | Complete revocation |